Exploring Potential Referral Pathways for Renal Artery Denervation and Developing a Centre of Excellence in Ireland.

Autor: Leahy N; Cardiology Department, University Hospital Galway, Saolta Healthcare Group, Newcastle Road, Galway, H91 YR71 Ireland.; University of Galway, University Road, Galway, Ireland., Wagener M; Cardiology Department, University Hospital Galway, Saolta Healthcare Group, Newcastle Road, Galway, H91 YR71 Ireland.; University of Galway, University Road, Galway, Ireland., Shahzad S; Cardiology Department, University Hospital Galway, Saolta Healthcare Group, Newcastle Road, Galway, H91 YR71 Ireland., Murphy D; Cardiology Department, University Hospital Galway, Saolta Healthcare Group, Newcastle Road, Galway, H91 YR71 Ireland.; University of Galway, University Road, Galway, Ireland., McMorrow A; Cardiology Department, University Hospital Galway, Saolta Healthcare Group, Newcastle Road, Galway, H91 YR71 Ireland.; University of Galway, University Road, Galway, Ireland., Coen E; Cardiology Department, University Hospital Galway, Saolta Healthcare Group, Newcastle Road, Galway, H91 YR71 Ireland.; University of Galway, University Road, Galway, Ireland., Sharif R; Cardiology Department, University Hospital Galway, Saolta Healthcare Group, Newcastle Road, Galway, H91 YR71 Ireland.; University of Galway, University Road, Galway, Ireland., Sharif F; Cardiology Department, University Hospital Galway, Saolta Healthcare Group, Newcastle Road, Galway, H91 YR71 Ireland.; University of Galway, University Road, Galway, Ireland.
Jazyk: angličtina
Zdroj: SN comprehensive clinical medicine [SN Compr Clin Med] 2024; Vol. 6 (1), pp. 32. Date of Electronic Publication: 2024 Mar 16.
DOI: 10.1007/s42399-024-01647-9
Abstrakt: Arterial hypertension is one of the most significant and prevalent risk factors for cardiovascular disease. Despite widespread awareness of the condition, as well as a multitude of available antihypertensive drug classes, rates of uncontrolled hypertension remain high on a global scale. Frequently, poor compliance with anti-hypertensive medication plays a big role in patients' inability to attain adequate blood pressure control. In individuals with resistant and/or uncontrolled hypertension, renal denervation is an emerging device-based therapy that has shown to be efficacious and safe in reducing blood pressure in several sham controlled trials. Additionally, it represents a treatment option for patients intolerant to oral pharmacotherapy. University Hospital Galway has been performing renal denervation procedures over the past number of years within multicentre, international sham-controlled trials and registries. Representing a novel and emerging antihypertensive treatment option, sources of referral for renal denervation are diverse and multiple; thus, there is an unmet need for standardised referral structures in Ireland. Herein, we review current and developing referral pathways for renal denervation at our institution, and discuss streamlined patient management and requirements to establish a centre of excellence.
Competing Interests: Competing InterestsMax Wagener has received educational support from Medtronic and Synapse Medical Sisk Healthcare. Faisal Sharif has received consultancy fees from Medtronic. Faisal Sharif has received research funding from Boston Scientific, Endotronix, and Medtronic. Niall Leahy, Shirjeel Shahzad, Darragh Murphy, Amy McMorrow, Eileen Coen, and Ruth Sharif have no conflicts of interest to declare.
(© The Author(s) 2024.)
Databáze: MEDLINE
Externí odkaz: